Edition:
United Kingdom

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

0.44USD
15 Feb 2019
Change (% chg)

$0.01 (+2.33%)
Prev Close
$0.43
Open
$0.44
Day's High
$0.45
Day's Low
$0.43
Volume
191,167
Avg. Vol
115,301
52-wk High
$2.90
52-wk Low
$0.36

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.49 -- --
ROI: -104.45 8.92 14.45
ROE: -153.83 10.08 15.96

Earnings vs. Estimates